• Research Category Research & Development Services & Subcontracts
• Solicitation Number S22-128
• NCI OA Contract Number 75N91019D00024 – NCI-FFRDC

Description

In support of the Clinical Proteomic Tumor Analysis Consortium (CPTAC), the scope of this solicitation is for Leidos Biomed to establish a portfolio of subcontractors with the capability to generate a series of mouse monoclonal antibodies from either protein or peptide immunogens used to immunize mice.

Proposal Instructions

Solicitation questions will be due by 1:00pm ET on Monday, November 14, 2022. To receive the full solicitation package please contact Kendra Schwieso.